Evaluation of antibody titer and associated risk factors of goat pox vaccine against lumpy skin disease in crossbred buffaloes
- PMID: 39951183
- PMCID: PMC11828800
- DOI: 10.1007/s11259-025-10673-4
Evaluation of antibody titer and associated risk factors of goat pox vaccine against lumpy skin disease in crossbred buffaloes
Abstract
Lumpy skin disease (LSD) is an infectious disease affecting large ruminants, caused by the lumpy skin disease virus (LSDV). It is characterized by symptoms such as hyperthermia, emaciation, lymphadenopathy, and skin nodules. Pregnant animals affected by LSD often experience abortions and may develop infertility syndrome, while affected males can become sterile. A live attenuated goat pox virus vaccine (GTPV) was administered to various groups of crossbred buffaloes. After vaccination, blood samples were collected from each group to analyze post-vaccination antibody titers. Additionally, vaccinated calves and buffaloes were monitored for growth, body temperature, blood profile, milk production and quality, and reproductive parameters. The study revealed an increase in antibody titer in the weeks following vaccination, with sustained levels for over 150 days before declining by 300 days. During the 7-day observational phase, the vaccinated calves and replacement heifers exhibited significant growth. There were no notable changes in body temperature or milk production in lactating buffaloes within 7 days post-vaccination. However, the buffalo category affected all blood profile indicators significantly (P < 0.05) except for MCHC (P > 0.05) after LSD vaccination. An interaction (P < 0.05) was observed between buffalo categories and days post-exposure for RBCs, HGB, HCT, and MCV values in vaccinated buffaloes. Reproductive parameters, including ovarian resumption, uterine involution rates, and synchronization rate, remained similar in both vaccinated and unvaccinated buffaloes. Overall, the use of the attenuated GTPV vaccine induces a considerable antibody titer without influencing general health or productive parameters, making it a safe and economical method for preventing LSD in buffaloes.
Keywords: Antibody titer; Crossbred buffaloes; Live-attenuated goat pox vaccine; Lumpy skin disease; Milk production; Reproductive performance.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Evaluation of the immune responses in buffaloes vaccinated with a live-attenuated lumpy skin disease vaccine (Lumpi-ProVacInd).Trop Anim Health Prod. 2024 Aug 2;56(7):226. doi: 10.1007/s11250-024-04089-6. Trop Anim Health Prod. 2024. PMID: 39093442
-
Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus.Vaccine. 2015 Jun 22;33(28):3256-61. doi: 10.1016/j.vaccine.2015.01.035. Vaccine. 2015. PMID: 26056063
-
Investigation on the incidence of adverse reactions, viraemia and haematological changes following field immunization of cattle using a live attenuated vaccine against lumpy skin disease.Transbound Emerg Dis. 2018 Feb;65(1):174-185. doi: 10.1111/tbed.12646. Epub 2017 Apr 8. Transbound Emerg Dis. 2018. PMID: 28391652
-
Efficacy of lumpy skin disease vaccines in cattle: a systematic review and meta-analysis.Microb Pathog. 2025 Sep;206:107836. doi: 10.1016/j.micpath.2025.107836. Epub 2025 Jun 25. Microb Pathog. 2025. PMID: 40578710
-
Progress in diagnostic methods and vaccines for lumpy skin disease virus: a path towards understanding the disease.Vet Res Commun. 2025 Mar 8;49(3):134. doi: 10.1007/s11259-025-10667-2. Vet Res Commun. 2025. PMID: 40056298 Free PMC article. Review.
Cited by
-
Pathogenicity and virulence of lumpy skin disease virus: A comprehensive update.Virulence. 2025 Dec;16(1):2495108. doi: 10.1080/21505594.2025.2495108. Epub 2025 Apr 27. Virulence. 2025. PMID: 40265421 Free PMC article. Review.
References
-
- Abutarbush SM, Tuppurainen ESM (2018) Serological and clinical evaluation of the yugoslavian RM65 Goat pox strain vaccine use in cattle against lumpy skin disease. Transbound Emerg Di 65:1657–1663 - PubMed
-
- Abutarbush SM, Ababneh MM, Al Zoubi IG (2015) Lumpy skin disease in Jordan: disease emergence, clinical signs, complications and preliminary-associated economic losses. Transbound Emerg Dis 62(5):549–554 - PubMed
-
- Agianniotaki EI, Babiuk S, Katsoulos P-D (2018) Colostrum transfer of neutralizing antibodies against lumpy skin disease virus from vaccinated cows to their calves. Transbound Emerg Dis 65(6):2043–2048 - PubMed
-
- Badhy SC, Chowdhury MGA, Settypalli TBK, Cattoli G, Lamien CE, Fakir MAU, Akter S, Osmani MG, Talukdar F, Begum N (2021) Molecular characterization of lumpy skin disease virus (LSDV) emerged in Bangladesh reveals unique genetic features compared to contemporary field strains. BMC Vet Res 17:61 - PMC - PubMed
MeSH terms
Substances
Grants and funding
- 31301972/Natural Science Foundation for Young Scientists of Shanxi Province
- 2008085MC94/Natural Science Foundation of Anhui Province
- 2018ZN014/Key research and development project of Chuzhou
- 202004f06020048/Key Research and development program of Anhui Province
- [2021]1146/Joint Research on Improved Beef Cattle Breeds in Anhui Province
LinkOut - more resources
Full Text Sources